HEALTH● LOW2h ago · Oct 19, 2026, 11:15 PM
FDA Grants Accelerated Approval to Dostarlimab for dMMR Rectal Cancer
ajmc.com · United States · north america
The FDA has granted accelerated approval for Dostarlimab to treat dMMR rectal cancer, signifying a new treatment option for this condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
SCI & TECH8h agoA 4.9-meter and 67.3-kilogram Burmese python was released in Florida while the United States Geological Survey tests drones to track invasive snakes in the EvergladesClarínBUSINESS11h agoConfirmed | These are the highest paying jobs in the United StatesClarínPOLITICS11h agoThe United States proposed dissolving the special United Nations committee where Argentina maintains its claim over the MalvinasClarínPOLITICS1d agoOfficial and confirmed | The new rule for applying for permanent residency in the United States that has already come into force: what it is about and which applicants it will affectClarín
More in Health
HEALTH46m agoRecognition Of Need To Fix Primary Care Crisis Good For Patientsscoop.co.nz · New ZealandHEALTH1h agoPSN seeks tougher penalties for drug fakers, proposes N25m fine, 20-year jail termVanguard NigeriaHEALTH2h agoHealthcare CIOs Need a Plan for November State Ballot Measures - hitconsultant.net · United StatesHEALTH2h agoPope Leo returns to work less than a week after lung cancer surgeryCBS News